GIST Cancer UK News

Please see the latest news, research and findings below...

Sarcoma Awareness Month – Just Giving Awards

July is Sarcoma Awareness month and we are delighted to say that our very own Jayne Bressington has been nominated for a Just Giving Award.  Jayne has done outstanding work in raising awareness of GIST and PAWS-GISTs in particular and in raising funds.  You can find out more and how to vote on the PAWS-GIST […]

Continue reading

GCUK partnering on Sarcoma UK Research Open Grant Round 2024

GIST Cancer UK  is partnering again this year with Sarcoma UK on their Open Grant Round 2024. We are interested in supporting research applications that: Target the unmet needs of Paediatric, Adolescent, Wild-Type and Syndromic (PAWS) GIST patients, including: improving our understanding of these subtypes developing novel therapeutic strategies and treatments Researchers can find further […]

Continue reading

IDRX-42 Phase 1b clinical trial in UK

Some GISTS develop resistance to standard drug treatment (e.g. imatinib, sunitinib, regorafenib, ripritinib).  A new drug is being trialed to prevent the emergence of sub-clones or to treat TKI resistant GISTs.  This trial is being coordinated by Professor Robin Jones at the Royal Marsden Hospital in London.

Continue reading

Merry Christmas to all

The GCUK Board would like to extend their appreciation to everyone for their work during the past year in supporting the charity, fellow patients and family, and wish you a merry festive season and best wishes for 2024.

Continue reading

Phase 2 Trial

Combination treatment with avelumab and regorafenib has shown activity in patients with relapsed/refractory gastrointestinal stromal tumors (GIST), according to research presented at the ESMO Congress 2023.

Continue reading